<VariationArchive VariationID="13617" VariationName="NM_000293.3(PHKB):c.1265dup (p.Asn422fs)" VariationType="Duplication" Accession="VCV000013617" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2014-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="28656" VariationID="13617">
      <GeneList>
        <Gene Symbol="PHKB" FullName="phosphorylase kinase regulatory subunit beta" GeneID="5257" HGNC_ID="HGNC:8927" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="47461299" stop="47701523" display_start="47461299" display_stop="47701523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="47495209" stop="47735433" display_start="47495209" display_stop="47735433" Strand="+" />
          </Location>
          <OMIM>172490</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000293.3(PHKB):c.1265dup (p.Asn422fs)</Name>
      <CanonicalSPDI>NC_000016.10:47596426:AAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="47596426" stop="47596427" display_start="47596426" display_stop="47596427" variantLength="1" positionVCF="47596426" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="47630337" stop="47630338" display_start="47630337" display_stop="47630338" variantLength="1" positionVCF="47630337" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>N415fs</ProteinChange>
      <ProteinChange>N422fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.47596433dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.47596433dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.47630344dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.47630344dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016598.1" sequenceAccession="NG_016598" sequenceVersion="1" change="g.140135dup">
            <Expression>NG_016598.1:g.140135dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000293.3" sequenceAccession="NM_000293" sequenceVersion="3" change="c.1265dup" MANESelect="true">
            <Expression>NM_000293.3:c.1265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000284.1" sequenceAccession="NP_000284" sequenceVersion="1" change="p.Asn422fs">
            <Expression>NP_000284.1:p.Asn422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031835.3" sequenceAccession="NM_001031835" sequenceVersion="3" change="c.1244dup">
            <Expression>NM_001031835.3:c.1244dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001027005.1" sequenceAccession="NP_001027005" sequenceVersion="1" change="p.Asn415fs">
            <Expression>NP_001027005.1:p.Asn415fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363837.1" sequenceAccession="NM_001363837" sequenceVersion="1" change="c.1265dup">
            <Expression>NM_001363837.1:c.1265dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350766.1" sequenceAccession="NP_001350766" sequenceVersion="1" change="p.Asn422fs">
            <Expression>NP_001350766.1:p.Asn422fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="172490.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000293.3(PHKB):c.1265dup (p.Asn422fs) AND Glycogen storage disease IXb" Accession="RCV000014587" Version="27">
        <ClassifiedConditionList TraitSetID="3748">
          <ClassifiedCondition DB="MedGen" ID="C0543514">Glycogen storage disease IXb</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-10" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2014-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9215682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326319</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3748" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1937" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXb</ElementValue>
                <XRef ID="Glycogen+storage+disease+IXb/8483" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009868" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IXb</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PHOSPHORYLASE KINASE DEFICIENCY OF LIVER AND MUSCLE, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD9B</ElementValue>
                <XRef Type="MIM" ID="261750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16711" />
                <XRef ID="16711" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="79240" DB="Orphanet" />
              <XRef ID="C0543514" DB="MedGen" />
              <XRef ID="MONDO:0009868" DB="MONDO" />
              <XRef Type="MIM" ID="261750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="34841" SubmissionDate="2014-04-29" DateLastUpdated="2014-05-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="172490.0001_GLYCOGEN STORAGE DISEASE IXb" title="PHKB, 1-BP INS_GLYCOGEN STORAGE DISEASE IXb" />
        <ClinVarAccession Accession="SCV000034841" DateUpdated="2014-05-10" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with glycogen storage disease IXb (GSD9B; 261750), Burwinkel et al. (1997) identified compound heterozygosity for 2 mutations in the PHKB gene. On 1 allele, a stretch of 7 A residues in exon 14 was extended by an additional A, resulting in a frameshift in codon 421 and translation termination at the following triplet; on the other allele, a C-to-T transition in exon 21 resulted in a gln656-to-ter (Q656X; 172490.0002) substitution. Studies in the parents indicated that the frameshift mutation had been inherited from the father and the nonsense mutation from the mother. The patient was the only child of unrelated, healthy German parents and presented at the age of 22 months because of distended abdomen due to hepatomegaly. At the age of 4 years, the child had a height at the tenth percentile and weight at the fiftieth percentile, hepatomegaly, and a tendency to develop hypoglycemic symptoms after several hours of fasting or physical activity. There were no clinical indications of muscle involvement.</Attribute>
              <Citation>
                <ID Source="PubMed">9215682</ID>
              </Citation>
              <XRef DB="OMIM" ID="261750" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKB" />
          </GeneList>
          <Name>PHKB, 1-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="172490.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE IXb</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6203616" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4346544|MedGen:C0543514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003514808" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9215682</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9326319</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9215682</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn422Lysfs*2) in the PHKB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PHKB are known to be pathogenic (PMID: 9215682, 9326319). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 9215682). ClinVar contains an entry for this variant (Variation ID: 13617). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.47630337_47630338insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0543514" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="34841" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE IXb" MappingRef="Preferred">
        <MedGen CUI="C0543514" Name="Glycogen storage disease IXb" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6203616" TraitType="Disease" MappingType="XRef" MappingValue="C0543514" MappingRef="MedGen">
        <MedGen CUI="C0543514" Name="Glycogen storage disease IXb" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

